IGHV1OR16-2

Across TCGA pan-cancer cohorts, IGHV1OR16-2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of IGHV1OR16-2’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where IGHV1OR16-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IGHV1OR16-2 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

LUAD, COAD, and READ are the cancer types where IGHV1OR16-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGHV1OR16-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.215	<.001	5	view →
COAD	All	All	−0.188	<.001	5	view →
READ	Female	All	−0.158	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

IGHV1OR16-2–LUAD

Open the LUAD breakdown →